DXB Ann: Dimerix confirms Phase 3 study design appropriate for China - 3rd Jul 2023, 8:36am

annb0t

annb0t

Top 20
DXB Ann: Dimerix confirms Phase 3 study design appropriate for China
Price Sensitive: Y
Date: 3rd Jul 2023, 8:36am

>>> Read announcement: Google: DXB Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
DXB Ann: Dimerix Appoints Chief Medical Officer - 23rd Oct 2023, 8:42am
Replies
0
Views
72
annb0t
annb0t
annb0t
DXB Ann: Dimerix Announces License Agreement for EU, Canada, ANZ - 5th Oct 2023, 8:43am
Replies
0
Views
73
annb0t
annb0t
annb0t
DXB Ann: Dimerix Receives $8.9M R&D Tax Incentive Rebate - 13th Sep 2023, 8:50am
Replies
0
Views
93
annb0t
annb0t
annb0t
DXB Ann: Dimerix presentation at Bioshares Biotech Summit - 24th Jul 2023, 12:00pm
Replies
0
Views
87
annb0t
annb0t
annb0t
DXB Ann: Dimerix to present at BIO International Convention - 6th Jun 2023, 8:50am
Replies
0
Views
97
annb0t
annb0t
Top Bottom